Dental Bone Graft Substitutes Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Dental Bone Graft Substitutes Market is Segmented by Product type (Xenograft, Allograft, Autograft, and Other Types), Mechanism (Osteoconduction, Osteoinduction, Osteogenesis, and Osteopromotion), End Users (Hospitals, Dental Clinics, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

CAGR
Study Period: 2018-2026
Base Year: 2020
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 6.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The dental bone graft substitutes market is expected to witness an estimated CAGR of 6.8% over the forecast period.

COVID-19 is having a major impact on the medical industry. As the total healthcare providers are engaged with COVID-19, the access is restricted to essential care only, and the temporary closure of dental clinics has drastically reduced dental surgeries. Even the treatment proximity to infected patients with COVID-19 is a challenge for dentists. The Journal of the American Medical Association stated that the rate of weekly visits to a dentist in the United States was 33% lower from March 2020 through August 2020, as compared to 2019. An article published in 2020 by the Centers for Disease Control and Prevention states that the United States government has reduced Medicaid dental coverage considering the fiscal conditions. These factors have a severe lead impact on dental bone graft substitute manufacturers and their supply chain.

The major factors responsible for the growth of the market studied include the rising incidence of dental diseases, rising demand for medical and dental tourism. According to the World Health Organization (2020), oral diseases affect nearly 3.5 billion people, and over 530 million children suffered from caries of primary teeth. Moreover, rising technological advancement and growing public awareness of preventive care are propelling the market growth. The American Dental Association (ADA) reported that more than 5 million implants are placed each year by dentists. To maintain the existing jaw, bone grafting before implant placement is being done, which further helps for successful implant surgery, increasing the use of synthetic and biocompatible grafts, also a major factor that is triggering the market. A study made on the global prevalence of periodontal disease, published on 28 May 2020 at PubMed, found that the distribution of periodontal disease increases with age. Periodontitis was the most common in older persons and in populations from high-income countries. The distribution differed significantly in low (28.7%), lower-middle (10%), upper-middle (42.5%), and high-income countries (43.7%). Hence, owing to the factors mentioned above, the market is expected to witness significant growth in the future.

Scope of the Report

Bone graft is used to fix problematic joints or damaged ones, which helps in growing bone around the implant. Bone grafting is performed before dental implants to restore missing teeth. Moreover, bone grafts are used as fillers and scaffolds in dentistry to facilitate bone formation and promote wound healing. They have no antigen-antibody reaction and are biodegradable. The dental bone grafts develop a new bone that acts as a mineral reservoir.

The dental bone graft substitutes market is segmented by product type (xenograft, allograft, autograft, and other types), mechanism (osteoconduction, osteoinduction, osteogenesis, and osteopromotion), end users (hospitals, dental clinics, and other end users), and geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Type
Xenograft
Allograft
Autograft
Other Types
By Mechanism
Osteoconduction
Osteoinduction
Osteogenesis
Osteopromotion
By End Users
Hospitals
Dental Clinics
Other End Users
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Xenogaft Segment is Expected to Grow Over the Forecast Period

A xenograft is an organ transplant or a tissue graft to an individual of other species. Xenografts are obtained from pigs (porcine) or cows (bovine). Xenografts are prepared for implantation into the human body once they are thoroughly cleaned and sterilized. Deproteinized bovine bone is the most common source of xenograft materials in the field of dentistry. Studies have found that 39% of new bone formation after six months of duration has been observed with maxillary sinus defect sites grafted with BioOss. In contrast, by following the grafting with autograft, it is reported that 40% of new bone formation takes place in the same duration of time. Few commercially available xenografts are Bio-Oss, Bio - Oss Collagen, Pepgen - P15, etc. As xenograft is most affordable, the key players in the market are taking initiatives to launch new products into the market. For instance, BioHorizons launched MinerOss X, xenograft products to develop dental implant procedures designed for sinus augmentation, ridge augmentation, grafting for implant placements, and extraction sockets. Hence, these factors may drive the segment growth in the future.

CAGR

North America Dominates the Market and Expected to do Same in the Forecast Period

North America holds the major market share in the dental bone graft substitute market. According to the Centers for Disease Control and Prevention, around 64.9% of adults aged 18 and above had dental visits in 2019 in the United States. A United States company, Dentsply Sirona, announced that it had acquired Datum Dental Ltd, known for innovative dental regeneration products, in January 2021. Dentsply Sirona and Datum Dental Ltd were already in distribution agreements since 2016. With this acquisition, Dentsply Sirona promotes the full OSSIX® portfolio (OSSIX Plus, OSSIX Volumax, and OSSIX Bone) in the United States, Canada, and several other countries.

As per Canada, health fact sheets, in 2018, around 74.7% of Canadians visited dentists, and almost two-thirds of Canadians (64.6%) have dental insurance to cover their expenses. Although general oral healthcare is not included in the Canada Health Act, they have several government programs to look into dental issues, such as dental coverage. These factors strongly pave the path for the dental bone graft substitutes market positively.

Geo

Competitive Landscape

The dental bone graft substitutes market is highly competitive, with several players across the world. In terms of market share, few of the major players currently dominate the market. With the rising patient awareness levels and high prevalence of dental disorders, many regional players are expected to be part of the dental bone graft substitute market over the forecast period. Some of the major players of the market are Dentsply Sirona, Johnson & Johnson, Institut Straumann AG, Medtronic PLC, ZIMMER BIOMET, etc.

Recent Developments

In January 2021, Dentsply Sirona announced the acquisition of Datum Dental Ltd, a leading provider of the innovative OSSIX regenerative solutions portfolio.

In October 2020, Fujifilm announced a clinical investigation in Europe on developing a new bone grafting material in the field of dentistry and oral surgery.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Demand of Medical and Dental Tourism

      2. 4.2.2 Rising Burden of Dental Diseases

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Expensive Dental Procedures

      2. 4.3.2 Reimbursement Issues

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Buyers/Consumers

      2. 4.4.2 Bargaining Power of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Xenograft

      2. 5.1.2 Allograft

      3. 5.1.3 Autograft

      4. 5.1.4 Other Types

    2. 5.2 By Mechanism

      1. 5.2.1 Osteoconduction

      2. 5.2.2 Osteoinduction

      3. 5.2.3 Osteogenesis

      4. 5.2.4 Osteopromotion

    3. 5.3 By End Users

      1. 5.3.1 Hospitals

      2. 5.3.2 Dental Clinics

      3. 5.3.3 Other End Users

    4. 5.4 By Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Dentsply Sirona

      2. 6.1.2 Johnson & Johnson

      3. 6.1.3 Institut Straumann AG

      4. 6.1.4 Medtronic PLC

      5. 6.1.5 ZIMMER BIOMET

      6. 6.1.6 Geistlich Pharm

      7. 6.1.7 Dentium

      8. 6.1.8 LifeNet Health

      9. 6.1.9 Collagen Matrix Inc.

      10. 6.1.10 Halma plc (Novabone LLC)

      11. 6.1.11 Botiss biomaterials GmbH

      12. 6.1.12 Wright Medical Group NV

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Dental Bone Graft Substitutes Market market is studied from 2018 - 2026.

The Global Dental Bone Graft Substitutes Market is growing at a CAGR of 6.8% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Dentsply Sirona, Johnson & Johnson, Institut Straumann AG, Medtronic PLC, ZIMMER BIOMET are the major companies operating in Global Dental Bone Graft Substitutes Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!